# Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3

> **NCT00273507** · PHASE3 · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 270 (—)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Carboplatin and Paclitaxel

## Key facts

- **NCT ID:** NCT00273507
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 270 (—)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273507, "Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00273507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*